SCHEMBL7477664

SCHEMBL7477664

CCN(c1c(Cl)c(C(F)(F)F)cc2nc(OC)c(N)nc12)S(C)(=O)=O

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.30
MAPT P10636 1/20 0.30
CCR4 P51679 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7468210 0.77 CCR4 (0.36) CCR4
SCHEMBL7466999 0.76 AURKA (0.32) CCR4
SCHEMBL7465352 0.74 EPAS1 (0.40) KDM4EMAPT
SCHEMBL7470542 0.70 GRIN1 (0.39)
SCHEMBL8488354 0.69 GRIN1 (0.40)
SCHEMBL7471473 0.66 GRIN1 (0.34) KDM4EMAPT
SCHEMBL7464603 0.66 GRIN1 (0.39)
SCHEMBL8487280 0.66 GRIN1 (0.35)
SCHEMBL8487286 0.66 GRIN1 (0.35)
SCHEMBL8930635 0.65 GRIN1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0783495-B1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER LTD (GB) 2002-02-27 EP disclosed
US-5852016-A Quinoxaline derivatives useful in therapy PFIZER INC. (US) 1998-12-22 US disclosed
EP-0783495-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY Pfizer Limited (GB) 1997-07-16 EP disclosed
WO-1996009295-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER LIMITED (GB) 1996-03-28 WO disclosed